Surgical treatment for pulmonary carcinoid tumors: a single-center analysis of 62 patients
10.3760/cma.j.issn.1001-4497.2012.04.015
- VernacularTitle:62例肺类癌的外科治疗及预后
- Author:
Feng YAO
;
Jun ZHOU
;
Chenxi ZHONG
;
Yu YANG
;
Heng ZHAO
- Publication Type:Journal Article
- Keywords:
Lung neoplasms;
Carcinoid tumors;
Thoracic surgical procedures;
Lymph node;
Neoplasm metastases;
Pathological type
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2012;28(4):233-236
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate prognostic factors and the surgical results of pulmonary carcinoid tumors.Methods We retrospectively reviewed the medical records of 62 patients who were diagnosed as pulmonary carcinoid tumors between January 2000 and October 2010 at Department of Thoracic Surgery,Shanghai Chest Hospital.The following information was available for each of the 62 patients:age,sex,pathological type,and TNM stage.ResultsThere were no operative death.The 3-year and 5-year survival rates after surgery were 92.1％ and 77.8％,respectively.Of the 62 patients,42 were diagnosed as typical carcinoid tumor,and among them,4 patients (8.3％) had lymph node metastases.Their 3-year and 5-year survival rates were 97.8％ and 94.7％,respectively.The remaining 20 patients were diagnosed as atypical carcinoid tumor,and among them,6 patients (37.5％) had lymph node metastases.Their 3-year and 5-year survival rates were 84.4％ and 58.8％,which were statistically significant compared with typical carcinoid tumor( P =0.0047 ).There was significant difference in survival rate between the patients with lymph node metastases and the patients without lymph node metastases (P =0.0048).CondusionThe main risk factors affecting survival rate of those patients who were diagnosed as pulmonary carcinoid tumors were pathological types and lymph node metastases.
